Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Humana
(NYSE:HUM)
Intraday
$335.59
0
[0.00%]
After-Hours
$335.59
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$335.59
0
[0.00%]
At close: May 10
$335.59
0
[0.00%]
PreMarket: 4:05PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Humana Stock (NYSE:HUM)
Humana Stock (NYSE: HUM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, May 10, 2024
Humana Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
-
2 days ago
Thursday, May 09, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
3 days ago
Tuesday, May 07, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
5 days ago
Monday, May 06, 2024
$100 Invested In This Stock 20 Years Ago Would Be Worth $2,000 Today
Benzinga Insights
-
6 days ago
Humana Unusual Options Activity For May 06
Benzinga Insights
-
6 days ago
Thursday, May 02, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
May 2, 2024, 1:35PM
Wednesday, May 01, 2024
Peering Into Humana's Recent Short Interest
Benzinga Insights
-
May 1, 2024, 10:15AM
Monday, April 29, 2024
Behind the Scenes of Humana's Latest Options Trends
Benzinga Insights
-
Apr 29, 2024, 1:45PM
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Shanthi Rexaline
-
Apr 29, 2024, 1:51AM
Thursday, April 25, 2024
Beyond The Numbers: 15 Analysts Discuss Humana Stock
Benzinga Insights
-
Apr 25, 2024, 3:00PM
RBC Capital Maintains Outperform on Humana, Lowers Price Target to $353
Benzinga Newsdesk
-
Apr 25, 2024, 12:10PM
UBS Maintains Neutral on Humana, Lowers Price Target to $326
Benzinga Newsdesk
-
Apr 25, 2024, 11:20AM
Cantor Fitzgerald Maintains Neutral on Humana, Lowers Price Target to $360
Benzinga Newsdesk
-
Apr 25, 2024, 10:42AM
Meta Platforms To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
-
Apr 25, 2024, 8:44AM
Oppenheimer Maintains Outperform on Humana, Lowers Price Target to $370
Benzinga Newsdesk
-
Apr 25, 2024, 8:14AM
Wednesday, April 24, 2024
Humana Withdraws Its Already Lowered 2025 Profit Guidance
Vandana Singh
-
Apr 24, 2024, 2:18PM
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?
Piero Cingari
-
Apr 24, 2024, 1:40PM
Humana Tops Q1 Earnings and Revenue Estimates
Zacks
-
Apr 24, 2024, 12:04PM
Humana shares are trading lower after the company said its EPS growth outlook will be impacted by several variables and said it no longer believes $6 to $10 of Adjusted EPS growth is the appropriate target range for 2025.
Benzinga Newsdesk
-
Apr 24, 2024, 11:39AM
Humana Earlier Said "Our 2025 Adj. EPS Growth Outlook Will Be Impacted By Several Variables To Which We Will Not Have Clear Visibility Until Later This Year; We Believe It Is Prudent To Provide More Specific Guidance For 2025 Once We Have Greater Clarity; We No Longer Believe $6 To $10 Of Adj. EPS Growth Is The Appropriate Target Range For 2025"
Benzinga Newsdesk
-
Apr 24, 2024, 11:35AM
Humana Announced Co Withdrew Its 2025 Profit Forecast
Benzinga Newsdesk
-
Apr 24, 2024, 11:14AM
Humana Boosts Medicare Advantage Membership 2024 Forecast As Q1 Earnings Performance Exceeds Expectations
Vandana Singh
-
Apr 24, 2024, 10:10AM
Humana shares are trading higher after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk
-
Apr 24, 2024, 6:38AM
Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally
Shanthi Rexaline
-
Apr 24, 2024, 6:37AM
Humana Raises 2024 Individual Medicare Advantage Annual Membership Growth By 50,000 To Now Anticipate Annual Growth Of 150,000, Or 2.8%
Benzinga Newsdesk
-
Apr 24, 2024, 6:36AM
Humana Affirms FY24 Adjusted EPS Outlook Of Approximately $16.00; Est $16.36
Benzinga Newsdesk
-
Apr 24, 2024, 6:34AM
Humana Q1 2024 Adj EPS $7.23 Beats $6.12 Estimate, Adj Sales $29.332B Beat $28.473B Estimate
Benzinga Newsdesk
-
Apr 24, 2024, 6:32AM
Tuesday, April 23, 2024
Behind the Scenes of Humana's Latest Options Trends
Benzinga Insights
-
Apr 23, 2024, 3:15PM
Cohere Health And Humana Expand Prior Authorization Partnership, Adding Diagnostic Imaging And Sleep Services
Benzinga Newsdesk
-
Apr 23, 2024, 9:07AM
Monday, April 22, 2024
Jefferies Maintains Buy on Humana, Lowers Price Target to $381
Benzinga Newsdesk
-
Apr 22, 2024, 3:01PM
Sunday, April 21, 2024
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Shanthi Rexaline
-
Apr 21, 2024, 5:45PM
Thursday, April 18, 2024
Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years
Benzinga Insights
-
Apr 18, 2024, 3:30PM
Wednesday, April 17, 2024
Smart Money Is Betting Big In HUM Options
Benzinga Insights
-
Apr 17, 2024, 1:32PM
Tuesday, April 16, 2024
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
Piero Cingari
-
Apr 16, 2024, 1:28PM
Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
Shanthi Rexaline
-
Apr 16, 2024, 7:24AM
Shares of healthcare stocks are trading higher in sympathy with UnitedHealth, which reported better-than-expected Q1 earnings.
Benzinga Newsdesk
-
Apr 16, 2024, 7:17AM
Monday, April 15, 2024
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
Vandana Singh
-
Apr 15, 2024, 2:17PM
Wednesday, April 10, 2024
Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $391 Price Target
Benzinga Newsdesk
-
Apr 10, 2024, 10:18AM
Tuesday, April 09, 2024
Behind the Scenes of Humana's Latest Options Trends
Benzinga Insights
-
Apr 9, 2024, 4:01PM
Monday, April 08, 2024
The Analyst Landscape: 21 Takes On Humana
Benzinga Insights
-
Apr 8, 2024, 9:00AM
Wells Fargo Maintains Overweight on Humana, Lowers Price Target to $350
Benzinga Newsdesk
-
Apr 8, 2024, 8:34AM
Friday, April 05, 2024
Check Out What Whales Are Doing With HUM
Benzinga Insights
-
Apr 5, 2024, 1:31PM
Thursday, April 04, 2024
Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $391 Price Target
Benzinga Newsdesk
-
Apr 4, 2024, 10:08AM
Wednesday, April 03, 2024
Healthcare Stocks Take a Hit After Trepidation In the Market Continues
MarketBeat
-
Apr 3, 2024, 6:05PM
Humana Unusual Options Activity
Benzinga Insights
-
Apr 3, 2024, 11:31AM
Goldman Sachs Maintains Buy on Humana, Lowers Price Target to $385
Benzinga Newsdesk
-
Apr 3, 2024, 11:14AM
Tuesday, April 02, 2024
Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $310
Benzinga Newsdesk
-
Apr 2, 2024, 2:52PM
TD Cowen Maintains Buy on Humana, Lowers Price Target to $396
Benzinga Newsdesk
-
Apr 2, 2024, 1:26PM
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Apr 2, 2024, 1:23PM
B of A Securities Downgrades Humana to Neutral, Lowers Price Target to $342
Benzinga Newsdesk
-
Apr 2, 2024, 1:18PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch